Target intelligence / Profile preview

Bacterial DNA and DNA-associated enzymes

Molecular classification
Enzyme, Nucleic acid, Isomerase, Transferase, DNA-binding protein
01

Overview

Bacterial DNA and DNA-associated enzymes represent a broad class of therapeutic targets essential for bacterial survival, growth, and reproduction (Molecular Biology of the Cell, 2002). This category includes the bacterial chromosome itself and the specialized enzymes required to maintain its topology and facilitate replication, such as DNA gyrase (Topoisomerase II) and Topoisomerase IV (StatPearls, 2023). These enzymes are distinct from human topoisomerases in structure and mechanism, allowing for selective toxicity in the treatment of bacterial infections (PubMed, PMC4933436). Antimicrobial agents targeting this system work through various mechanisms: fluoroquinolones stabilize enzyme-DNA complexes to induce lethal double-strand breaks, while nitroimidazoles like metronidazole are reduced to reactive intermediates that directly damage the DNA structure (PubChem, 2024). These targets are fundamental in treating a vast array of infectious diseases, ranging from simple urinary tract infections to life-threatening sepsis and tuberculosis, though the emergence of multi-drug resistant strains remains a significant clinical challenge (WHO, 2023).

Other names
Bacterial genomeDNA replication machineryBacterial topoisomerasesBacterial DNA-binding proteinsBacterial replisome
02

Mechanism of action

Inhibition of DNA gyrase and topoisomerase IV to prevent DNA untangling and replication; direct induction of DNA strand breaks through reactive metabolites; inhibition of DNA-dependent RNA polymerase to block transcription.

03

Biological functions

DNA replicationDNA repairDNA supercoilingTranscriptionGenetic inheritanceDecatenation
04

Disease associations

InfectionSepsisPneumoniaTuberculosisUrinary tract infectionMeningitis
05

Safety considerations

Antimicrobial resistanceDisruption of commensal microbiotaTendon rupture and tendinitis (associated with fluoroquinolones)QT interval prolongationHepatotoxicityNeurotoxicity
06

Interacting drugs

Ciprofloxacin

7 more in the full profile.

07

Biomarkers

Bacterial DNA load (qPCR)Minimum Inhibitory Concentration (MIC)ProcalcitoninC-reactive proteinBacterial colony forming units (CFU)

Beyond the preview

Go deeper on Bacterial DNA and DNA-associated enzymes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial DNA and DNA-associated enzymes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call